To test whether tumor myeloid cells utilize C/EBPβ to drive an M2 phenotype in prostate cancer, we evaluated Hi-Myc tumors in C/EBPβ(f/f) and C/EBPβ(f/f);Lys-Cre mice. This evidence concerns the gene CEBPB and prostate carcinoma.